The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

24 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
4
Anti-inflammatory tetraquinane diterpenoids from a Crinipellis species.EBI
University of Kaiserslautern
39
Optimization of pyrazole-containing 1,2,4-triazolo-[3,4-b]thiadiazines, a new class of STAT3 pathway inhibitors.EBI
University of Pittsburgh
32
2-Guanidinoquinazolines as new inhibitors of the STAT3 pathway.EBI
University of Pittsburgh
2
Anti-inflammatory drimane sesquiterpene lactones from an Aspergillus species.EBI
Institute of Biotechnology and Drug Research (Ibwf)
4
Direct interaction of garcinol and related polyisoprenylated benzophenones of Garcinia cambogia fruits with the transcription factor STAT-1 as a likely mechanism of their inhibitory effect on cytokine signaling pathways.EBI
University of Salerno
80
Inhibiting aberrant signal transducer and activator of transcription protein activation with tetrapodal, small molecule Src homology 2 domain binders: promising agents against multiple myeloma.EBI
University of Toronto Mississauga
23
Small molecule inhibitors of signal transducer and activator of transcription 3 (Stat3) protein.EBI
University of Southern California
10
Small molecule STAT5-SH2 domain inhibitors exhibit potent antileukemia activity.EBI
University of Toronto
3
Discovery of SD-436: A Potent, Highly Selective and Efficacious STAT3 PROTAC Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression.EBI
University of Michigan
34
Design of a potent and selective dual JAK1/TYK2 inhibitor.EBI
Galapagos NV
37
Identification and Biological Evaluation of a Potent and Selective JAK1 Inhibitor for the Treatment of Pulmonary Fibrosis.EBI
Ewha Womans University
1
Selectivity through Targeted Protein Degradation (TPD).EBI
AstraZeneca
37
Rational drug design of benzothiazole-based derivatives as potent signal transducer and activator of transcription 3 (STAT3) signaling pathway inhibitors.EBI
Fudan University
2
SD-91 as A Potent and Selective STAT3 Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression.EBI
University of Michigan
11
Structure-Based Discovery of SD-36 as a Potent, Selective, and Efficacious PROTAC Degrader of STAT3 Protein.EBI
TBA
3
A small-molecule screen identifies the antitrypanosomal agent suramin and analogues NF023 and NF449 as inhibitors of STAT5a/b.EBI
Leipzig University
188
Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinasesBDB
Array Biopharma
42
Compounds for cancer chemotherapeutic sensitizationBDB
University of Minnesota
83
Substituted benzothienyl-pyrrolotriazines and uses thereof in the treatment cancerBDB
Bayer Intellectual Property
260
Compounds as modulators of RORγBDB
Boehringer Ingelheim International
73
Substituted benzimidazole-type piperidine compounds and uses thereofBDB
Purdue Pharma
4
Crystal structure of Staphylococcus aureus tyrosyl-tRNA synthetase in complex with a class of potent and specific inhibitors.BDB
Gsk
11
Discovery of novel 2,3-diarylfuro[2,3-b]pyridin-4-amines as potent and selective inhibitors of Lck: synthesis, SAR, and pharmacokinetic properties.BDB
Amgen
13
Synthesis, Biological Activity, and Crystal Structure of Potent Nonnucleoside Inhibitors of HIV-1 Reverse Transcriptase That Retain Activity against Mutant Forms of the Enzyme.BDB
Nci-Fcrdc